Cardiovascular Drugs Market – SGLT2 Inhibitors Expanding Beyond Diabetes into Heart Failure
Market OverviewSGLT2 inhibitors are expanding beyond diabetes into heart failure and chronic kidney disease, reshaping the cardiovascular drugs market through a powerful cardiorenal treatment paradigm. These therapies reduce hospitalization for heart failure and slow kidney disease progression, leading guidelines to adopt them as foundational therapy across multiple indications. The...
0 Комментарии 0 Поделились 202 Просмотры 0 предпросмотр
SocioMint https://sociomint.com